期刊文献+

冠心病患者β受体阻滞剂的应用研究及防治 被引量:5

下载PDF
导出
摘要 目的 了解冠心病患者二级预防用药中β受体阻滞剂的应用及防治。方法 选取行冠脉造影明确诊断为冠心病的患者300例,进行病史询问,了解患者基本临床资料填写问卷,建立患者基本档案。分析患者对冠心病的知晓率、冠心病二级预防用药现状、不同心率组基线资料,以及β受体阻滞剂未规范使用的原因。结果 (1)冠心病的知晓率分析,调查显示300例患者知晓率仅达20%。(2)冠心病二级预防药物的服药情况,阿司匹林服药率为90.0%,ACEI/ARB服药率为73.4%,β受体阻滞剂服药率为90.0%,他汀类服药率为81.3%。(3)心率为80-90次/min的患者并存更多的心血管危险因素,尿素、肌酐、吸烟、高血压均较其他组有显著差异。(4)分析未规范用药的原因包括:1药品费用贵;2出现不良反应;3缺乏对冠心病的了解,无症状不需要服药;4缺乏用药知识;5担心不良反应;6自理能力差;7医生未开医嘱。结论 (1)患者对冠心病的了解甚少;(2)目前冠心病二级预防在实践中贯彻得并不理想;(3)临床对冠心病患者β受体阻滞剂的使用率偏低、剂量偏小;(4)心率快的冠心病患者比心率慢的患者并存更多的心血管危险因素;(5)导致患者未规范用药的原因较多,患者服药依从性差;(6)心内科医生应重视冠心病二级预防具体措施的落实,加大卫生宣教,社会应加大对慢性病预防的投入。 Objective Understanding application and prevention aboutβ-blockers in Secondary prevention medication of Coronary Heart Disease. Methods To elected 300 patients that are diagnosed of coronary heart disease. Collecting General situation, to understand the patient's awareness of coronary heart disease, Secondary prevention of coronary heart disease medication Situation, compare data different groups of heart rate,. the reason analysis aboutβ-blockers did not regulate. Results (1)Analysis of coronary heart disease awareness 300 patients, coronary heart disease awareness is only 20%. (2)The taking the drug situation of Secondary prevention: Aspirin 90%, ACEI/ARB 73.4%, β-blockers 90%, Statins 81.3%; (3)Heart rate of 80-90 beats / min in patients with additional cardiovascular risk factors coexist, urea, creatinine, smoking, high blood pressure than those in the other groups were significantly different. (4)The reason analysis about Coronary Heart Disease did not regulate medication; ①Expensive drugs; ②Side effects; ③Lack of understanding of coronary heart disease; ④Lack of medication knowledge; ⑤Fear of side effects; ⑥Poor self-care; ⑦The doctor did not prescribe medication. Conclusion (1)lack of the knowledge of coronary heart disease; (2)Currently implement secondary prevention of coronary heart disease was not ideal in practice; (3)Clinical coronary artery disease in patients with β-blocker usage low dose is small; (4)Fast heart rate in patients with coronary heart disease coexisting more cardiovascular risk factors; (5)Many causes of without standard medication; (6)Cardiologists should pay attention to the implementation of specific measures for secondary prevention of coronary heart disease, should increase health education, community should increase investment in chronic disease prevention.
出处 《当代医学》 2016年第33期7-9,共3页 Contemporary Medicine
关键词 冠心病 二级预防 Β受体阻滞剂 Coronary heart disease Secondary prevention β-blockers status
  • 相关文献

参考文献4

二级参考文献15

  • 1无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2072
  • 2赵冬,刘群.中国冠心病二级预防架桥工程进展——初步调查结果分析报告[J].中华医学信息导报,2007,22(1):19-19. 被引量:18
  • 3柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2146
  • 4胡大一,孙艺红.优化的药物治疗是冠心病二级预防的基石[J].中华内科杂志,2007,46(6):442-443. 被引量:42
  • 5Fox KA, Goodman SG, Anderson FA, et al. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. Eur Heart J, 2003,24: 1414-1424.
  • 6Eagle KA, Goodman SG, Avezum A, et al. Practice variation and missed opportunities for reperfusion in ST-segment elevation myocardial infarction - findings from the Global Registry of Acute Coronary Events (GRACE). Lancet, 2002,359 : 373-377.
  • 7Ryan TJ, Antman EM, Brokks NH, et al. For the committee on management of acute myocardial infarction. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol, 1999,34: 890-911.
  • 8The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Acute myocardial infarction: pre-hospital and in-hospital management. Eur Heart J, 1996, 17:43 -63.
  • 9Granger C, Sendon JL, Van de Weft F, et al. Applying the evidence in acute coronary syndromes: a report card from the global registry of acute coronary events. J Am Coll Cardiol, 2001,37 (Suppl A):503A.
  • 10Newby LK, La Pointe NM, Chen AY, et al. Long - term adherence to evidence - based secondary prevention therapies in coronary artery disease[J] . Circulation, 2006,113(2) :203.

共引文献114

同被引文献90

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部